One consistent finding in heart failure therapy for the last decade has been the singular
utility of the angiotensin converting enzyme (ACE) inhibitors. At least six of these agents …

Angiotensin-converting enzyme (ACE) inhibitors are the first-line drugs for the treatment of
congestive heart failure, but many patients could not receive those benefits because of …

Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce morbidity and
mortality in patients with heart failure due to systolic left ventricular dysfunction and are …

Background: Trials evaluating angiotensin‐receptor blockers in heart failure (HF) have
shown inconsistent results. Objective: To evaluate the effect of angiotensin II (AII) receptor …

Although the beneficial effects of angiotensin-con verting enzyme (ACE) inhibitors on symp
toms. morbidity and mortality have been proven beyond any doubt, some controversies …

The title of the proposed series of reviews is Translational Success Stories. The definition of
“translation” according to Webster is,“an act, process, or instance of translating as a …

Congestive heart failure is a common clinical syndrome and recent epidemiologic surveys
indicate that its incidence is increasing. It has been estimated that as many as four million …

A comment on this article appears in" Clinical implications of increased plasma angiotensin
II concentrations despite ACE inhibitor therapy in patients with congestive heart failure: the …

ACE inhibitors have significantly decreased cardiovascular mortality, myocardial infarction
(MI), and hospitalizations for heart failure (HF) in patients with asymptomatic or symptomatic …

We read with great interest the review on angiotensin II type 1 receptor blockers by Michel
Burnier. 1 He quotes previous investigations, including the results of the Losartan Heart …